Finance

Lists
524396:BOM
Biofil Chemicals and Pharmaceuticals Ltd
30,01 ₹
+0,13%
(+0,040) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524396...
Open
30,99 ₹
High
30,99 ₹
Low
30,01 ₹
Mkt. cap
491,14 млн
Avg. vol.
3,96 мың
Volume
219,00
P/E ratio
99,76
52-wk high
46,82 ₹
52-wk low
25,60 ₹
EPS
0,30 ₹
No. of employees
24
Open
30,99 ₹
High
30,99 ₹
Low
30,01 ₹
Mkt. cap
491,14 млн
Avg. vol.
3,96 мың
Volume
219,00
P/E ratio
99,76
52-wk high
46,82 ₹
52-wk low
25,60 ₹
EPS
0,30 ₹
No. of employees
24
News stories
From web sources and news partners
About Biofil Chemicals and Pharmaceuticals Ltd
CEO-
Employees24
Founded1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
136,04 млн
9,35 млн
45,92 млн
124,13 млн
Cost of goods sold
131,71 млн
4,25 млн
64,65 млн
118,45 млн
Cost of revenue
131,71 млн
4,25 млн
64,65 млн
118,45 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,55 млн
3,36 млн
-1,56 млн
3,64 млн
Operating expense
3,21 млн
4,02 млн
6,22 млн
4,33 млн
Total operating expenses
134,92 млн
8,27 млн
70,87 млн
122,78 млн
Operating income
1,12 млн
1,07 млн
-24,96 млн
1,35 млн
Other non operating income
-
-
-10,00 мың
-
EBT including unusual items
1,12 млн
1,07 млн
4,69 млн
1,34 млн
EBT excluding unusual items
1,12 млн
1,07 млн
-23,43 млн
1,34 млн
Income tax expense
281,00 м.
275,00 м.
2,57 млн
250,00 м.
Effective tax rate
25,16%
25,77%
54,72%
18,64%
Other operating expenses
-
-
7,04 млн
-
Net income
836,00 м.
792,00 м.
2,12 млн
1,09 млн
Net profit margin
0,61%
8,47%
4,62%
0,88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,54 млн
-
Interest expense
-1,00 мың
-5,00 мың
-
-7,00 мың
Net interest expenses
-1,00 мың
-5,00 мың
1,54 млн
-7,00 мың
Depreciation and amortization charges
660,00 м.
660,00 м.
740,00 м.
684,00 м.
EBITDA
1,78 млн
2,02 млн
-24,28 млн
2,03 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары